Tirz
This page provides a neutral reference point for the Tirz listing at Inno Peptides. Confirm the exact identity and specifications from the current product listing and available documentation rather than relying on a shortened product name. See the full listing for available details and documentation.
Tirz — Tirzepatide Research Information
Tirz is a commonly used shortened name for tirzepatide, a synthetic peptide studied for its activity at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
This Inno Peptides product page provides compound information, listed size options, and links to scientific resources. Product identity and batch-specific specifications should be confirmed using the applicable product label and documentation.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Tirz |
| Compound Name | Tirzepatide |
| Compound Classification | Dual GIP and GLP-1 receptor agonist |
| Available Listed Sizes | 10 mg, 30 mg, and 60 mg |
| Product Format | Confirm from current product packaging |
| Purity | Refer to applicable batch-specific documentation |
| Laboratory Documentation | Consult available certificates and analytical records |
The listed sizes should match the options available on the current product page. Confirm the actual quantity and compound identity against the product label and applicable batch documentation.
About Tirzepatide
Tirzepatide is a synthetic peptide that acts on GIP and GLP-1 receptors. These signalling pathways are involved in metabolic regulation and have been studied in clinical and laboratory research.
Scientific information about tirzepatide does not independently verify the identity, purity, or quantity of any particular commercial product. Batch-specific claims should be supported by appropriate documentation.
Research Context and Scientific Literature
For scientific background and published research, consult the following resources:
These resources provide scientific and clinical-trial information. They do not certify or verify a specific commercial product.
Documentation and Quality Information
When reviewing research materials, consult the applicable Certificate of Analysis (COA), batch identifier, and available analytical documentation.
Purity, identity, and quantity claims should be supported by documentation corresponding to the specific lot. No independent purity percentage or batch-specific test result is claimed here without supporting evidence.
For questions about available product records, visit the Inno Peptides Contact page or explore the Research Resources page.
Handling and Storage
Follow the product label and applicable supplier documentation for handling, storage, and laboratory safety. Do not assume a specific storage temperature, shelf life, or stability period without product-specific supporting information.
Explore More at Inno Peptides
- Shop All Products
- Research Peptides
- Research Resources
- About Inno Peptides
- Frequently Asked Questions
Orders and Customer Support
For questions about product availability, listed sizes, or available documentation, visit our Contact page.
You can also review our Shipping Policy, Refund Policy, and Terms and Conditions.
Important Research Notice
Tirzepatide is a prescription medicine in approved formulations and is not approved for general use in unapproved research-product formulations. This page provides general scientific information and is not medical advice. The product should not be represented as suitable for human or veterinary consumption or self-administration.
Always review applicable product documentation, laboratory safety requirements, and relevant regulations before handling research materials.
| vails | 10 mg, 30 mg, 60 mg |
|---|
